CO6400217A2 - (1-fenil-2-piridin-4-il)etil esteres del acido benzoico como inhibidores de fosfodiesterasa - Google Patents
(1-fenil-2-piridin-4-il)etil esteres del acido benzoico como inhibidores de fosfodiesterasaInfo
- Publication number
- CO6400217A2 CO6400217A2 CO11098671A CO11098671A CO6400217A2 CO 6400217 A2 CO6400217 A2 CO 6400217A2 CO 11098671 A CO11098671 A CO 11098671A CO 11098671 A CO11098671 A CO 11098671A CO 6400217 A2 CO6400217 A2 CO 6400217A2
- Authority
- CO
- Colombia
- Prior art keywords
- phenyl
- piridin
- benzoic acid
- ethyl esters
- phosphodiesterase inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/14—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se relaciona con inhibidores de la enzima fosfodiesterasa 4 (PDE4). Más particularmente, la invención se relaciona con los derivados de -fenil-2-piridinil alquilo alcoholes, métodos para preparar tales compuestos, composiciones que los comprenden, combinaciones y usos terapéuticos de los mismos (I) en donde n es 0 o 1; R1 y R2 pueden ser iguales o diferentes, y son seleccionados del grupo que consiste de: -alquilo C1-C6 lineal o ramificado, OR3 en donde R3 es un alquilo C1-C6 lineal o ramificado opcionalmente substituido por uno o más grupos cicloalquilo C3-C7; y - HNSO2R4 en donde R4 es alquilo C1-C4 opcionalmente substituido con uno o más átomos de halógeno o con un grupo C1-C4, en donde por lo menos uno de R1 y R2 es HNSO2R4. Las otras variables son como se definió en las reivindicaciones.-
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09001660A EP2216327A1 (en) | 2009-02-06 | 2009-02-06 | Benzoic acid (1-phenyl-2-pyridin-4-yl)ethyl esters as phosphodiesterase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6400217A2 true CO6400217A2 (es) | 2012-03-15 |
Family
ID=40674203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO11098671A CO6400217A2 (es) | 2009-02-06 | 2011-08-04 | (1-fenil-2-piridin-4-il)etil esteres del acido benzoico como inhibidores de fosfodiesterasa |
Country Status (34)
Country | Link |
---|---|
US (5) | US8440834B2 (es) |
EP (2) | EP2216327A1 (es) |
JP (2) | JP5612610B2 (es) |
KR (1) | KR101337728B1 (es) |
CN (1) | CN102317262B (es) |
AR (1) | AR075243A1 (es) |
AU (1) | AU2010211274B2 (es) |
BR (1) | BRPI1005695A8 (es) |
CA (1) | CA2751494C (es) |
CL (1) | CL2011001876A1 (es) |
CO (1) | CO6400217A2 (es) |
CY (1) | CY1113764T1 (es) |
EA (1) | EA019113B1 (es) |
ES (1) | ES2395528T3 (es) |
GE (1) | GEP20135919B (es) |
HK (1) | HK1162508A1 (es) |
HR (1) | HRP20121004T1 (es) |
IL (1) | IL214446A (es) |
JO (1) | JO2761B1 (es) |
MA (1) | MA33105B1 (es) |
ME (1) | ME02325B (es) |
MX (1) | MX2011007857A (es) |
MY (1) | MY152048A (es) |
NZ (1) | NZ594413A (es) |
PE (1) | PE20120055A1 (es) |
PL (1) | PL2393782T3 (es) |
PT (1) | PT2393782E (es) |
RS (1) | RS52605B (es) |
SG (1) | SG173208A1 (es) |
SI (1) | SI2393782T1 (es) |
TN (1) | TN2011000346A1 (es) |
TW (1) | TWI459945B (es) |
UA (1) | UA102574C2 (es) |
WO (1) | WO2010089107A1 (es) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2022783A1 (en) | 2007-08-08 | 2009-02-11 | CHIESI FARMACEUTICI S.p.A. | "Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors" |
EP2216327A1 (en) * | 2009-02-06 | 2010-08-11 | CHIESI FARMACEUTICI S.p.A. | Benzoic acid (1-phenyl-2-pyridin-4-yl)ethyl esters as phosphodiesterase inhibitors |
JP6004233B2 (ja) | 2010-08-03 | 2016-10-05 | チェシ ファーマスーティシ エス.ピー.エイ. | ホスホジエステラーゼ阻害剤を含む乾燥粉末製剤 |
CN103052378A (zh) | 2010-08-03 | 2013-04-17 | 奇斯药制品公司 | 包含磷酸二酯酶抑制剂的药物制剂 |
AR086676A1 (es) * | 2011-06-06 | 2014-01-15 | Chiesi Farma Spa | Derivados de alcoholes 1-fenil-2-piridinil alquilicos como inhibidores de fosfodiesterasa |
CN103827088B (zh) * | 2011-09-26 | 2017-10-13 | 奇斯药制品公司 | 作为磷酸二酯酶抑制剂的1‑苯基‑2‑吡啶基烷基醇的衍生物 |
RU2617401C2 (ru) | 2011-10-21 | 2017-04-25 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Производные 1-фенил 2-пиридинилалкиловых спиртов в качестве ингибиторов фосфодиэстеразы |
AR089232A1 (es) * | 2011-12-16 | 2014-08-06 | Chiesi Farma Spa | Potenciacion inducida por inhibidores de pde4 en el tratamiento de la leucemia |
CA2875421A1 (en) * | 2012-06-04 | 2013-12-12 | Chiesi Farmaceutici S.P.A. | Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
EP2928879B1 (en) | 2012-12-05 | 2018-02-28 | Chiesi Farmaceutici S.p.A. | Phenylethylpyridine derivatives as pde4-inhibitors and muscarinic receptor antagonists |
BR112015012720A2 (pt) * | 2012-12-05 | 2017-07-11 | Chiesi Farm Spa | derivados de feniletilpiridina como inibidores de pde4 |
CA2893622A1 (en) * | 2012-12-05 | 2014-06-12 | Chiesi Farmaceutici S.P.A. | Novel compounds |
EP2928869B1 (en) * | 2012-12-05 | 2019-02-20 | Chiesi Farmaceutici S.p.A. | 1-phenyl-2-pyridinyl alkyl alcohol derivatives as phosphodiesterase inhibitors |
US9427376B2 (en) | 2013-10-10 | 2016-08-30 | Chiesi Farmaceutici S.P.A. | Process for preparing pharmaceutical formulations for inhalation comprising a high-dosage strength active ingredient |
EP3060551B1 (en) * | 2013-10-22 | 2019-09-18 | Chiesi Farmaceutici S.p.A. | Process for the preparation of a pde4 inhibitor |
CA2932486A1 (en) | 2013-12-05 | 2015-06-11 | Chiesi Farmaceutici S.P.A. | Benzhydryl derivatives for the treatment of respiratory diseases |
US9133185B2 (en) | 2013-12-05 | 2015-09-15 | Chiesi Farmaceutici S.P.A | Heteroaryl derivatives |
US9890151B2 (en) | 2014-06-04 | 2018-02-13 | Chiesi Farmaceutici S.P.A. | 3,5-dichloro,4-(3,4-(cyclo-)alkoxyphenyl)- 2-carbonyloxy)ethyl)pyridine derivatives as PDE-4 inhibitors |
US10087176B2 (en) | 2014-06-04 | 2018-10-02 | Chiesi Farmaceutici S.P.A. | 3,5-dichloro,4-(3,4-(cyclo-)alkoxyphenyl)--2-carbonyloxy)ethyl)pyridine derivatives as PDE-4 inhibitors |
US9326976B2 (en) * | 2014-06-05 | 2016-05-03 | Chiesi Farmaceutici S.P.A. | Carbamate derivatives |
US9763924B2 (en) | 2014-06-05 | 2017-09-19 | Chiesi Farmaceutici S.P.A. | Aminoester derivatives |
WO2017089347A1 (en) | 2015-11-25 | 2017-06-01 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas |
EP3487501A1 (en) * | 2016-07-20 | 2019-05-29 | Allergan, Inc. | Methods, compositions, and compounds for treatment of dermatological and ocular conditions |
BR112020012972A2 (pt) | 2017-12-28 | 2020-11-24 | Chiesi Farmaceutici S.P.A. | uso de derivados de álcool 1-fenil-2-piridinil alquílico para tratar fibrose cística |
WO2020020957A1 (en) | 2018-07-27 | 2020-01-30 | Chiesi Farmaceutici S.P.A. | Novel carrier particles for dry powder formulations for inhalation |
CN115466169B (zh) * | 2021-06-10 | 2024-03-26 | 中国医学科学院药物研究所 | 取代邻苯二酚醚类化合物及其制备方法和应用 |
CN118475343A (zh) | 2021-12-21 | 2024-08-09 | 凯西制药公司 | 填充在具有改善的耐湿性的吸入器中的干粉制剂 |
WO2023208982A1 (en) | 2022-04-27 | 2023-11-02 | Chiesi Farmaceutici S.P.A. | Crystal form of a pde4 inhibitor |
WO2024027901A1 (en) | 2022-08-02 | 2024-02-08 | Chiesi Farmaceutici S.P.A. | Predictive biomarker of clinical response to a pde4 inhibitor |
WO2024062005A1 (en) | 2022-09-22 | 2024-03-28 | Chiesi Farmaceutici S.P.A. | Capsule inhaler for the administration of a phosphodiesterase-4 inhibitor |
WO2024062006A1 (en) | 2022-09-22 | 2024-03-28 | Chiesi Farmaceutici S.P.A. | Capsule inhaler for the administration of a phosphodiesterase-4 inhibitor |
WO2024062007A1 (en) | 2022-09-22 | 2024-03-28 | Chiesi Farmaceutici S.P.A. | Capsule inhaler for the administration of a phosphodiesterase-4 inhibitor |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW263495B (es) * | 1992-12-23 | 1995-11-21 | Celltech Ltd | |
GB9304919D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
AU687087B2 (en) | 1993-07-02 | 1998-02-19 | Takeda Gmbh | Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors |
GB9412573D0 (en) * | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
ATE496029T1 (de) | 2006-07-14 | 2011-02-15 | Chiesi Farma Spa | Derivate von 1-phenyl-2-pyridinylalkylenalkohole als phosphodiesteraseinhibitoren |
EP2022783A1 (en) | 2007-08-08 | 2009-02-11 | CHIESI FARMACEUTICI S.p.A. | "Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors" |
EP2070913A1 (en) | 2007-12-14 | 2009-06-17 | CHIESI FARMACEUTICI S.p.A. | Ester derivatives as phosphodiesterase inhibitors |
EP2110375A1 (en) | 2008-04-14 | 2009-10-21 | CHIESI FARMACEUTICI S.p.A. | Phosphodiesterase-4 inhibitors belonging to the tertiary amine class |
EP2216327A1 (en) * | 2009-02-06 | 2010-08-11 | CHIESI FARMACEUTICI S.p.A. | Benzoic acid (1-phenyl-2-pyridin-4-yl)ethyl esters as phosphodiesterase inhibitors |
CN103052378A (zh) | 2010-08-03 | 2013-04-17 | 奇斯药制品公司 | 包含磷酸二酯酶抑制剂的药物制剂 |
JP6004233B2 (ja) | 2010-08-03 | 2016-10-05 | チェシ ファーマスーティシ エス.ピー.エイ. | ホスホジエステラーゼ阻害剤を含む乾燥粉末製剤 |
AR086676A1 (es) | 2011-06-06 | 2014-01-15 | Chiesi Farma Spa | Derivados de alcoholes 1-fenil-2-piridinil alquilicos como inhibidores de fosfodiesterasa |
CN103827088B (zh) | 2011-09-26 | 2017-10-13 | 奇斯药制品公司 | 作为磷酸二酯酶抑制剂的1‑苯基‑2‑吡啶基烷基醇的衍生物 |
RU2617401C2 (ru) | 2011-10-21 | 2017-04-25 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Производные 1-фенил 2-пиридинилалкиловых спиртов в качестве ингибиторов фосфодиэстеразы |
CA2875421A1 (en) | 2012-06-04 | 2013-12-12 | Chiesi Farmaceutici S.P.A. | Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
EP2928869B1 (en) | 2012-12-05 | 2019-02-20 | Chiesi Farmaceutici S.p.A. | 1-phenyl-2-pyridinyl alkyl alcohol derivatives as phosphodiesterase inhibitors |
-
2009
- 2009-02-06 EP EP09001660A patent/EP2216327A1/en not_active Withdrawn
-
2010
- 2010-02-03 JO JO201033A patent/JO2761B1/en active
- 2010-02-04 AU AU2010211274A patent/AU2010211274B2/en active Active
- 2010-02-04 PL PL10704746T patent/PL2393782T3/pl unknown
- 2010-02-04 GE GEAP201012324A patent/GEP20135919B/en unknown
- 2010-02-04 BR BRPI1005695A patent/BRPI1005695A8/pt not_active Application Discontinuation
- 2010-02-04 WO PCT/EP2010/000676 patent/WO2010089107A1/en active Application Filing
- 2010-02-04 AR ARP100100311A patent/AR075243A1/es not_active Application Discontinuation
- 2010-02-04 EP EP10704746A patent/EP2393782B1/en active Active
- 2010-02-04 SG SG2011056165A patent/SG173208A1/en unknown
- 2010-02-04 EA EA201190099A patent/EA019113B1/ru unknown
- 2010-02-04 UA UAA201108827A patent/UA102574C2/ru unknown
- 2010-02-04 PE PE2011001441A patent/PE20120055A1/es active IP Right Grant
- 2010-02-04 MA MA34150A patent/MA33105B1/fr unknown
- 2010-02-04 KR KR1020117016842A patent/KR101337728B1/ko active IP Right Grant
- 2010-02-04 PT PT107047466T patent/PT2393782E/pt unknown
- 2010-02-04 JP JP2011548600A patent/JP5612610B2/ja active Active
- 2010-02-04 RS RS20120547A patent/RS52605B/en unknown
- 2010-02-04 ES ES10704746T patent/ES2395528T3/es active Active
- 2010-02-04 CN CN201080006643.7A patent/CN102317262B/zh active Active
- 2010-02-04 CA CA2751494A patent/CA2751494C/en active Active
- 2010-02-04 MY MYPI2011003639 patent/MY152048A/en unknown
- 2010-02-04 NZ NZ594413A patent/NZ594413A/xx unknown
- 2010-02-04 SI SI201030094T patent/SI2393782T1/sl unknown
- 2010-02-04 MX MX2011007857A patent/MX2011007857A/es active IP Right Grant
- 2010-02-04 TW TW099103291A patent/TWI459945B/zh active
- 2010-02-04 ME MEP-2016-19A patent/ME02325B/me unknown
- 2010-02-05 US US12/700,926 patent/US8440834B2/en active Active
-
2011
- 2011-07-13 TN TN2011000346A patent/TN2011000346A1/fr unknown
- 2011-08-04 IL IL214446A patent/IL214446A/en active IP Right Grant
- 2011-08-04 CO CO11098671A patent/CO6400217A2/es not_active Application Discontinuation
- 2011-08-04 CL CL2011001876A patent/CL2011001876A1/es unknown
-
2012
- 2012-03-28 HK HK12103106.1A patent/HK1162508A1/xx unknown
- 2012-09-14 US US13/618,346 patent/US20130012487A1/en not_active Abandoned
- 2012-12-04 CY CY20121101183T patent/CY1113764T1/el unknown
- 2012-12-06 HR HRP20121004AT patent/HRP20121004T1/hr unknown
-
2013
- 2013-06-28 US US13/930,304 patent/US8648204B2/en active Active
- 2013-12-17 US US14/108,731 patent/US8859778B2/en active Active
-
2014
- 2014-09-04 JP JP2014179895A patent/JP2015038079A/ja active Pending
- 2014-09-10 US US14/482,287 patent/US9056176B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6400217A2 (es) | (1-fenil-2-piridin-4-il)etil esteres del acido benzoico como inhibidores de fosfodiesterasa | |
AR077986A1 (es) | Derivados de ester del acido 2,5-furandicarboxilico y su uso como plastificantes | |
CL2009000089A1 (es) | Procesos de preparacion de un derivado del acido y-amino-o-bifenil-x-metil-pentanoico;compuestos intermediarios y su proceso de preparacion; uso de los compuestos en la sintesis de compuestos inhibidores de nep, utiles en enfermedades cardiovasculares, tales como hipertension, insuficiencia cardiaca congestiva, entre otras. | |
ECSP10010129A (es) | Inhibidores de quinasas símil polo | |
UY33337A (es) | DERIVADOS SUSTITUIDOS DE 1H-PIRAZOL[ 3,4-d]PIRIMIDINA COMO INHIBIDORES DE LAS FOSFOINOSITIDA 3-QUINASAS | |
ECSP11010889A (es) | INHIBIDORES DE cMET | |
PA8779101A1 (es) | "compuestos tricíclicos como inhibidores de metaloproteinasas matriciales" | |
AR072906A1 (es) | Nucleosidos modificados utiles como antivirales | |
CO6541606A2 (es) | Espiroindolinona- pirrolidinas | |
UY32077A (es) | Inhibidores de quinasa tipo polo | |
PE20151448A1 (es) | Compuestos de tiazolcarboxamidas y piridinacarboxamida utiles como inhibidores de quinasa pim | |
UY32630A (es) | Derivados de 7-aza-espiro[3.5]nonano-7-carboxilatos, su preparación y su aplicación en terapéutica. | |
SV2011003855A (es) | Heteroarilos sustituidos | |
HN2010001459A (es) | Derivados de carboxamidas azabiciclicas, su preparacion y su preparacion en terapeutica. | |
BR112014029551A2 (pt) | compostos de ácido dimetil-benzoico | |
BR112014032741A2 (pt) | lipase em esterificação de ácidos graxos de cadeia curta | |
NZ596228A (en) | Compositions and methods for the treatment of inflammation | |
CR10780A (es) | Inhibidores de cinasa | |
UY31523A1 (es) | Procedimiento para la preparacion de esteres alquilicos de acidos grasos | |
BR112013001942A2 (pt) | ester de ácidos carboxílicos hidróxi o-substituído, processo para produzir pelo menos um éster de ácidos hidróxi carboxílicos o-substituídos, e, composição cosmética | |
UY32246A (es) | Derivados de carbamatos de alquil-heterociclos, su preparación y su aplicación en terapéutica | |
BR112014002672A2 (pt) | composições compreendendo monoésteres de isossorbida e dióis vicinais alifáticos | |
UY33177A (es) | Derivados de ácido carboxílico que comprenden un anillo de oxazolopirimidina 2, 5, 7-sustituido | |
AR085428A1 (es) | (3r,4r)-4-ciano-3,4-difenilbutanoatos sustituidos, procedimiento para su preparacion y su uso como herbicidas y reguladores de crecimiento de plantas | |
UY33179A (es) | Derivados de ácido carboxílico que comprenden un anillo de oxazolopirimidina 2,5-sustituido. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |